Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.
about
Management of borderline and locally advanced pancreatic cancer: where do we stand?Cancer concepts and principles: primer for the interventional oncologist-part IIChemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging TreatmentsAntitumour effect of polyoxomolybdates: induction of apoptotic cell death and autophagy in in vitro and in vivo models.Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.A phase I/II trial of intensity modulated radiation (IMRT) dose escalation with concurrent fixed-dose rate gemcitabine (FDR-G) in patients with unresectable pancreatic cancer.Inhibition of RAC1 GTPase sensitizes pancreatic cancer cells to γ-irradiation.Recent advances in combined modality therapyModeling Combined Chemotherapy and Particle Therapy for Locally Advanced Pancreatic CancerMultidisciplinary neoadjuvant management for potentially curable pancreatic cancer.A phase I study of cetuximab in combination with gemcitabine and radiation for locally advanced pancreatic cancerNeoadjuvant chemoradiation in patients with pancreatic adenocarcinoma.Treatment of locally advanced unresectable pancreatic cancer: a 10-year experience.Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.Adjuvant gemcitabine and concurrent radiation for patients with resected pancreatic cancer: a phase II study.Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer.Comparison of CT and PET-CT based planning of radiation therapy in locally advanced pancreatic carcinomaA phase I trial of Capecitabine+Gemcitabine with radical radiation for locally advanced pancreatic cancer.Improving gemcitabine-mediated radiosensitization using molecularly targeted therapy: a reviewA phase I, dose-finding study of sorafenib in combination with gemcitabine and radiation therapy in patients with unresectable pancreatic adenocarcinoma: a Grupo Español Multidisciplinario en Cáncer Digestivo (GEMCAD) study.An evaluation of gemcitabines differential radiosensitising effect in related bladder cancer cell lines.Biodegradable Polymersomes for the Delivery of Gemcitabine to Panc-1 Cells.Resectable pancreatic cancer: the role for neoadjuvant/preoperative therapy.
P2860
Q26825414-379B6F0D-DD0D-4609-A544-CB4FE613805EQ27010961-23C2CC80-1DC2-485A-A463-92A51A48DE11Q28079705-8EE655F9-B134-48FC-9D6A-1972E630DDC8Q33310804-3C327CCD-8C4E-423C-93D2-9784C47410CDQ33389524-DBEFBA35-C403-4F02-B730-BE573B1C592BQ33400984-5174D785-CDE7-489C-8C27-168B9128747AQ34786416-72172AAD-3150-4337-B197-43509FF10B6FQ35584002-AACF53EC-7109-4A85-9260-77AFC3F07BE0Q35820403-648EBC68-8519-481A-876F-AE9BF92DF786Q36023889-869E49B5-8C9A-43BE-831B-6BA8E0F003FBQ36206894-5A6BFB62-5D16-49BA-88A0-C78F461E5589Q36253159-B7A9A723-6409-4B9E-B00A-7A4D852064ABQ36381222-ACCB1F64-9526-4D34-85CF-DDB3811BC222Q36476666-000E71CD-B51B-4E0E-906A-61940796522AQ36612113-C681A4A9-253C-4828-909A-AC5138B7DDB0Q36626082-3BDA9C13-D782-4353-B0F4-AF6632E1F696Q36924872-AE20DF11-74E4-40B1-A175-F0E56A9E8008Q37080999-53B973CF-7FF6-40B3-80B8-98A64F82AD76Q37230970-9847D86E-CBDC-4055-AE11-EC0A7F78CB51Q37458491-152460A7-B226-414A-A452-A590D2C73F7EQ38796157-B1C177FA-EB88-4565-A9D4-E03DEFBE73D3Q40745423-0285F2B1-B027-41F3-A534-CCFB36CE00D1Q42153645-FD9E0669-9178-401C-9679-6B2E2F33FC68
P2860
Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Phase I trial of gemcitabine c ...... ced pancreatic adenocarcinoma.
@en
Phase I trial of gemcitabine c ...... ced pancreatic adenocarcinoma.
@nl
type
label
Phase I trial of gemcitabine c ...... ced pancreatic adenocarcinoma.
@en
Phase I trial of gemcitabine c ...... ced pancreatic adenocarcinoma.
@nl
prefLabel
Phase I trial of gemcitabine c ...... ced pancreatic adenocarcinoma.
@en
Phase I trial of gemcitabine c ...... ced pancreatic adenocarcinoma.
@nl
P2093
P1476
Phase I trial of gemcitabine c ...... nced pancreatic adenocarcinoma
@en
P2093
C Charnsangavej
D M Gravel
J L Abbruzzese
N A Janjan
P W Pisters
P304
P407
P577
2001-08-01T00:00:00Z